37
Janus Henderson Biotech Innovation Fund II Access raises $155M as hedge fund with 610 investors
Fund raise update · Hedge fund · Open-ended · Offering Indefinite · Sold $155M · NEW YORK, NY · filed 2026-10-13
3(c)(7) — qualified purchasers
57
Janus Henderson Biotech Innovation Fund II Access LLC files an open-ended hedge fund fund
New fund · Hedge fund · Open-ended · NEW YORK, NY · Form D filed 2025-09-16
3(c)(7) — qualified purchasersFirst filing by this entityrepeat_fund_numeralNeeds prime broker / custodyFeeder / access vehiclePlacement agent engaged
Why now — by persona
Relevant to: Fund administrator, Fund audit & tax, Custodian / prime broker, Compliance consultant / RIA registration. Lead card pending.
People on the filing
| n/a Asterion Fund Services, L.L.C. | Manager of the Issuer |
| n/a "iCapital Alternative Investments LLC (""iCapital"")" | Administrator of the Issuer |
| n/a "Maples Fiduciary Services (Delaware) Inc. (""MFSD Inc."")" | Managing Member of the Manager of the Issuer |
| Edward L. Truitt, Jr. | Executive Officer |
| Scott L. Huff | Executive Officer |
| Andrea L. Capeci | Executive Officer |
Signed by Andrea Capeci, Chief Financial Officer of the Administrator.
Placement agents / sales compensation: Merrill Lynch, Pierce, Fenner & Smith Incorporated
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.